Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study-Reference-Cited by-同舟云学术

Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study

Published:2021-03 Issue: Volume:146 Page:107-114
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Martinelli Giovanni,Boissel Nicolas,Chevallier Patrice,Ottmann Oliver^ORCID,Gökbuget Nicola,Rambaldi Alessandro,Ritchie Ellen K.^ORCID,Papayannidis Cristina,Tuglus Catherine A.,Morris Joan D.,Stein Anthony

Funder

Amgen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges;Soverini;J Hematol Oncol,2019

2. Philadelphia chromosome-positive acute lymphoblastic leukemia;Ravandi;Hematol Oncol Clin N Am,2009

3. Complete hematologic and molecular response in adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia following treatment with blinatumomab: results from a phase II, single-arm, multicenter study;Martinelli;J Clin Oncol,2017

4. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy;Soverini;Mol Canc,2018

5. Current and future management of Ph/BCR-ABL positive ALL;Maino;Expert Rev Anticancer Ther,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

2. Immunotherapy in first line treatment of adult acute lymphoblastic leukemia;Current Opinion in Oncology;2024-08-13

3. Current landscape of CD3 bispecific antibodies in hematologic malignancies;Trends in Cancer;2024-08

4. Bispecific antibodies: advancing precision oncology;Trends in Cancer;2024-08

5. Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL;Journal of Clinical Oncology;2024-07-19